TCA
AMGN icon

Transcend Capital Advisors’s Amgen AMGN Stock Holding History

Transcend Capital Advisors’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.5M Sell
4,263
-55
-1% -$19.6K 0.12% 164
2025
Q4 		$1.41M Sell
4,318
-1,947
-31% -$618K 0.11% 171
2025
Q3 		$1.77M Sell
6,265
-88
-1% -$25.5K 0.12% 164
2025
Q2 		$1.77M Sell
6,353
-1,176
-16% -$333K 0.14% 158
2025
Q1 		$2.35M Sell
7,529
-3,130
-29% -$924K 0.17% 143
2024
Q4 		$2.78M Sell
10,659
-501
-4% -$149K 0.2% 121
2024
Q3 		$3.6M Buy
11,160
+53
+0.5% +$17.3K 0.24% 105
2024
Q2 		$3.47M Buy
11,107
+404
+4% +$119K 0.25% 96
2024
Q1 		$3.04M Buy
10,703
+202
+2% +$59.1K 0.24% 96
2023
Q4 		$3.02M Sell
10,501
-101
-1% -$27.5K 0.27% 91
2023
Q3 		$2.85M Buy
10,602
+372
+4% +$92.8K 0.28% 81
2023
Q2 		$2.27M Sell
10,230
-86
-0.8% -$20K 0.22% 109
2023
Q1 		$2.49M Sell
10,316
-22
-0.2% -$5.4K 0.26% 97
2022
Q4 		$2.72M Buy
10,338
+30
+0.3% +$8.04K 0.3% 83
2022
Q3 		$2.32M Sell
10,308
-93
-0.9% -$22.5K 0.26% 103
2022
Q2 		$2.53M Sell
10,401
-494
-5% -$121K 0.26% 101
2022
Q1 		$2.63M Buy
10,895
+713
+7% +$164K 0.24% 112
2021
Q4 		$2.29M Buy
10,182
+993
+11% +$210K 0.2% 116
2021
Q3 		$1.92M Sell
9,189
-231
-2% -$53.2K 0.17% 136
2021
Q2 		$2.3M Buy
9,420
+293
+3% +$72.1K 0.33% 80
2021
Q1 		$2.26M Sell
9,127
-62
-0.7% -$14.8K 0.27% 94
2020
Q4 		$2.11M Buy
9,189
+2,759
+43% +$636K 0.28% 95
2020
Q3 		$1.63M Buy
+6,430
New +$1.59M 0.3% 84
2020
Q2 		– Sell
-7,210
Closed -$1.47M – 120
2020
Q1 		$1.47M Buy
7,210
+300
+4% +$65.5K 0.44% 67
2019
Q4 		$1.67M Buy
+6,910
New +$1.52M 0.45% 70

Other funds holding AMGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Transcend Capital Advisors's AMGN Position: Q1 2026 in Review

Transcend Capital Advisors reduced its Amgen (AMGN) stake by 1.3% in Q1 2026, selling an estimated $19.6K and leaving 4,263 shares worth $1.5M. The position accounts for 0.12% of the portfolio, ranked #164.

Transcend Capital Advisors first reported a position in AMGN in Q4 2019 and has held it in 25 quarters since. The position peaked at $3.6M in Q3 2024. 3,131 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Transcend Capital Advisors held 4,263 shares of Amgen worth $1.5M as of Q1 2026.
  • Transcend Capital Advisors sold 55 Amgen shares in Q1 2026, an estimated $19.6K.
  • Amgen made up 0.12% of Transcend Capital Advisors's portfolio in Q1 2026, its #164 holding.
  • Transcend Capital Advisors first reported a position in Amgen in Q4 2019 and has held it in 25 quarters since.
  • Transcend Capital Advisors's Amgen position peaked at $3.6M in Q3 2024.
  • 3,131 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Transcend Capital Advisors's 13F filing for Q1 2026, filed 13 May 2026.